Side effects from daily aspirin treatment in patients with AERD: Identification and management

Allergy and Asthma Proceedings

Volumn 32, Issue 5, 2011, Pages 333-334

  White, Andrew A ^a   Stevenson, Donald D ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CLOPIDOGREL; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; STEROID;

ASPIRIN EXACERBATED RESPIRATORY DISEASE; BLEEDING; DESENSITIZATION; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERANCE; DRUG WITHDRAWAL; EDITORIAL; EPISTAXIS; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; KIDNEY DYSFUNCTION; LOW DRUG DOSE; LUNG HEMORRHAGE; NAUSEA; RISK FACTOR; SIDE EFFECT; STOMACH DISEASE; STOMACH PAIN; UTERUS CONTRACTION;

ASPIRIN; HUMANS; RESPIRATORY HYPERSENSITIVITY;

EID: 80053427486     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2011.32.3437     Document Type: Editorial

References (9)

1. Baker T, and Quinn J. Aspirin therapy in aspirin-exacerbated respiratory disease: A risk-benefit analysis for the practicing allergist. Allergy Asthma Proc 32:335-340, 2011.
2. Pleskow WW, Stevenson DD, Mathison DA, et al. Aspirin desensitization in aspirin-sensitive asthmatic patients: Clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol 69:11-9, 1982. (Pubitemid 12210227)
3. Rozsasi A, Polzehl D, Deutschle T, et al. Long-term treatment with aspirin desensitization: A prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy 63:1228-1234, 2008.
4. Lee JY, Simon RA, and Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol 119:157-164, 2007. (Pubitemid 46037806)
5. Hansen RA, Tu W, Wang J, et al. Risk of adverse gastrointestinal events from inhaled corticosteroids. Pharmacotherapy 28:1325-1334, 2008.
6. Piper JM, Ray WA, Daugherty JR, and Griffin MR. Corticosteroid use and peptic ulcer disease: Role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 114:735-740, 1991.
7. Laheij RJ, Sturkenboom MC, Hassing RJ, et al. Risk of community- acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292:1955-1960, 2004. (Pubitemid 39411203)
8. Yang, YX, Lewis JD, Epstein S, and Metz, DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947, 2006.
9. O'Donoghue ML, Braunwald E, Antman EM, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: An analysis of two randomized trials. Lancet 374:989, 2009.